The Global Plant-based Hemostat Powder Market was valued at USD 185.36 Million in 2023 and is projected to reach USD 254.13 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 5.40% during the forecast period (2024–2029). This robust growth is propelled by the rising volume of surgical procedures worldwide, an increasing preference for biocompatible and absorbable hemostatic agents, and significant advancements in plant-based medical technologies across both hospital and ambulatory surgical settings.

As the healthcare industry continues to prioritize patient safety and improved surgical outcomes, the focus intensifies on innovative companies developing effective and natural solutions for bleeding control. In this blog, we profile the Top 10 Companies in the Plant-based Hemostat Powder Industry—a dynamic mix of established medical device giants and specialized biotech firms that are defining the future of hemostasis.

Download FREE Sample Report:
Global Plant-based Hemostat Powder Market – View in Detailed Research Report

---

🔟 1. Johnson & Johnson (Ethicon)

Headquarters: New Brunswick, New Jersey, USA
Key Offering: SURGIFLO® Haemostatic Matrix, ETHICON Absorbable Hemostat Powders

Johnson & Johnson, through its Ethicon subsidiary, is a global leader in surgical care and a pioneer in hemostasis. The company offers a comprehensive portfolio of plant-based hemostatic agents, primarily utilizing purified porcine gelatin in powder form, which is highly effective in controlling capillary and venous bleeding during surgery.

Innovation & Market Initiatives:

• Continuous R&D to enhance the efficacy and application of absorbable hemostats
• Extensive clinical data supporting the safety profile of its plant-based powders
• Global distribution network ensuring product availability in over 100 countries

---

9️⃣ 2. Baxter International Inc.

Headquarters: Deerfield, Illinois, USA
Key Offering: FLOSEAL® Hemostatic Matrix

Baxter is a cornerstone in the hemostasis market, renowned for its FLOSEAL product—a combination of gelatin matrix and thrombin. This plant-based (gelatin) powder expands upon contact with blood to provide rapid hemostasis in surgical settings, including cardiac, spinal, and vascular procedures.

Innovation & Market Initiatives:

• Strategic focus on sealing the portfolio gap with innovative hemostatic solutions
• Investment in manufacturing scalability to meet growing global demand
• Commitment to advancing surgical outcomes through evidence-based products

---

8️⃣ 3. BD (Becton, Dickinson and Company)

Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: Hemostatic agents through its Integrated Surgery Solutions

BD is a leading global medical technology company with a strong presence in the surgical hemostasis space. While its portfolio is diverse, it includes advanced plant-based hemostatic solutions designed for ease of use and reliability in controlling bleeding, complementing its extensive range of surgical products.

Innovation & Market Initiatives:

• Integration of hemostatic agents into broader surgical workflow solutions
• Focus on developing products that minimize surgical complications
• Global reach through a well-established medical supply chain

Download FREE Sample Report:
Global Plant-based Hemostat Powder Market – View in Detailed Research Report

---

7️⃣ 4. Celox Ltd.

Headquarters: Manchester, United Kingdom
Key Offering: Celox™ Hemostatic Granules

Celox is a specialist in hemostasis, famous for its chitosan-based hemostatic products. While chitosan is often derived from shellfish, the company also engages in plant polysaccharide technology. Its granule/powder formulations are designed for rapid hemostasis in trauma and surgical scenarios, working independently of the body’s clotting mechanism.

Innovation & Market Initiatives:

• Specialization in advanced chitosan and plant-polysaccharide hemostats
• Strong focus on trauma and emergency medicine applications
• Ongoing research into next-generation biodegradable hemostatic materials

---

6️⃣ 5. Hemostasis, LLC

Headquarters: Saint Petersburg, Florida, USA
Key Offering: Plant-based absorbable hemostatic powders (e.g., Stasis®)

Hemostasis, LLC is a key player focused specifically on developing and marketing plant-derived hemostatic agents. The company’s products are engineered to be highly absorbable and effective, catering to a niche but growing segment of surgeons seeking natural alternatives to synthetic or animal-derived hemostats.

Innovation & Market Initiatives:

• Dedicated R&D in plant polysaccharide chemistry for medical use
• Targeted marketing towards minimally invasive surgical procedures
• Building partnerships with regional distributors in emerging markets

---

5️⃣ 6. Biocer Entwicklungs-GmbH

Headquarters: Bayreuth, Germany
Key Offering: CERAMENT™ |BONE VOID FILLER with hemostatic properties

Biocer is a German company specializing in bioceramic materials for medical applications. While its core focus is bone regeneration, its injectable bone void filler, CERAMENT, exhibits inherent hemostatic properties. The company leverages plant-derived and other natural components to create biocompatible solutions that support the body’s healing processes.

Innovation & Market Initiatives:

• Expertise in combining osteoconduction with hemostasis
• Innovation in ready-to-use, pre-mixed paste formulations
• Strong presence in the European orthopedic and trauma surgery markets

---

4️⃣ 7. Grena Ltd.

Headquarters: London, United Kingdom
Key Offering: Plant-based absorbable hemostatic agents

Grena is a medical device company known for its innovative surgical products, including hemostatic solutions. The company focuses on developing reliable and easy-to-use plant-based hemostatic powders that integrate seamlessly into various surgical procedures, particularly in general and gynecological surgery.

Innovation & Market Initiatives:

• Product development centered on surgeon feedback and clinical needs
• Expansion of product indications for broader surgical applicability
• Commitment to producing high-purity, plant-sourced medical materials

Download FREE Sample Report:
Global Plant-based Hemostat Powder Market – View in Detailed Research Report

---

3️⃣ 8. Pfizer Inc. (Acquisition-based presence)

Headquarters: New York, New York, USA
Key Offering: Hemostatic products through its Hospital Business Unit

As a pharmaceutical behemoth, Pfizer’s presence in the hemostasis market is significant, though often through acquisitions and partnerships. The company markets and distributes a range of surgical products, including plant-based hemostatic agents, leveraging its vast global commercial infrastructure to serve hospitals and surgical centers.

Innovation & Market Initiatives:

• Leveraging global commercial strength to distribute hemostatic products
• Strategic acquisitions to bolster its surgical and hospital product portfolio
• Focus on integrated therapeutic solutions for perioperative care

---

2️⃣ 9. Medtronic plc

Headquarters: Dublin, Ireland
Key Offering: Hemostatic agents via its Surgical Innovations division

Medtronic, a world leader in medical technology, offers a variety of solutions for surgical hemostasis. While its portfolio is extensive, it includes advanced sealants and hemostats that utilize plant-based components. The company’s focus is on providing comprehensive solutions that improve surgical efficiency and patient recovery.

Innovation & Market Initiatives:

• Integration of hemostatic products with energy-based surgical devices
• Investment in regenerative medicine technologies incorporating natural polymers
• Extensive clinical education programs for surgeons on advanced hemostasis techniques

---

1️⃣ 10. Stryker Corporation

Headquarters: Kalamazoo, Michigan, USA
Key Offering: Hemostatic products through its Neurotechnology, Spine, and Orthopedics divisions

Stryker is a dominant force in the medical equipment sector, with a substantial portfolio in surgical devices and supplies. The company offers hemostatic agents, including plant-based powders, that are critical for controlling bleeding in complex orthopedic, spinal, and neurosurgeries, aligning with its mission to make healthcare better.

Innovation & Market Initiatives:

• Development of site-specific hemostatic solutions for different surgical specialties
• Acquisition of innovative startups to enhance its biologics and surgical solutions portfolio
• Global supply chain optimization to ensure product availability

Get Full Report Here:
Global Plant-based Hemostat Powder Market – View in Detailed Research Report

---

🔬 Outlook: The Future of Hemostasis is Biocompatible and Precision-Based

The plant-based hemostat powder market is undergoing a significant evolution. While traditional agents remain foundational, the industry is heavily investing in next-generation biomaterials, combination products, and formulations tailored for specific surgical applications.

📈 Key Trends Shaping the Market:

• Increased R&D into novel plant-derived polymers like starch, chitosan, and cellulose
• Growing demand for products that minimize immunogenic response and promote healing
• Rise of ambulatory surgery centers (ASCs) driving demand for efficient hemostatic agents
• Strategic mergers and acquisitions consolidating the market and expanding product portfolios

Get Full Report Here:
Global Plant-based Hemostat Powder Market – View in Detailed Research Report

The companies listed above are not only supplying critical tools for surgical teams worldwide—they are actively pioneering the next wave of biocompatible medical innovation to enhance patient care and surgical outcomes.